Peter S. Nelson

Fred Hutch Cancer Center — United States

Medicine · Health Sciences

113h-index65.3kcitations1.5kworks1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(1025), Cancer, Lipids, and Metabolism(273), Hormonal and reproductive studies(153), Prostate Cancer Diagnosis and Treatment(142), Molecular Biology Techniques and Applications(135)

Publications1.5k total

Global mRNA 3′UTR lengthening in small-cell neuroendocrine carcinoma
2026Open Access
Phenotypic discovery and therapeutic evaluation of an <i>ITGA3B1</i> -targeting antibody-drug conjugate for bladder cancer
Science Advances·2026Open Access
The Multifaceted Role of Androgen Receptor Signaling in Immunity: Implications for Oncology
Molecular Cancer Research·2025Open Access
Featured Cover
Histopathology·2025Open Access
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis
Histopathology·2025· 1 cited
Supplementary Figures from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S5 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S4 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S2 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S1 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S3 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2025Open Access
Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
2025Open Access
Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
2025Open Access
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer
Oncogene·2025Open Access
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Nature Genetics·2025· 1 citedOpen Access
778 CRISPR screens reveal innate immune checkpoints regulating NK cell sensitivity across solid tumors
Regular and Young Investigator Award Abstracts·2025Open Access
Targeting the Androgen Receptor Pathway in Prostate Cancer: A PROTrACted Struggle
Clinical Cancer Research·2025Open Access
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer
2025Open Access
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer
Nature Communications·2025· 2 citedOpen Access
Author response: Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
2025Open Access
page 1 of 74Next →

Frequent Co-authors

Ilsa M. Coleman(19), Lawrence D. True(18), Elahe A. Mostaghel(16), Bruce Montgomery(15), Colm Morrissey(12), Robert L. Vessella(11), Johann S. de Bono(9), Colin C. Pritchard(8), Howard I. Scher(8), Philip W. Kantoff(8), Himisha Beltran(7), Stephen R. Plymate(7), Mark A. Rubin(7), Dan R. Robinson(6), Eliezer M. Van Allen(6), Nikolaus Schultz(6), Arul M. Chinnaiyan(6), Celestia S. Higano(6), Jared M. Lucas(6), Eva Corey(6)